Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Sep 30
Love0

Individual Article: Evaluation of Efficacy and Tolerability of Two Over-the-Counter Eczema Itch Relief Products

By Chuck Lin No Comments
INTRODUCTIONEczema, also called atopic dermatitis, is an inflammatory skin disease characterized by skin barrier damage, which translates to itch, dry skin, rash, scaling, blisters, and skin their eczema flares, patients…
Read More
Sep 30
Love0

FULL SUPPLEMENT: Brodalumab: Five Years of Real-World Safety and Efficiency

By Chuck Lin No Comments
In this supplement: Brodalumab is an Efficacious, Safe, and Cost-Effective IL-17 Receptor Blocker for the Treatment of Moderate-to-Severe Plaque Psoriasis: 2023 UpdatePsoriasis remains a highly prevalent condition in the United…
Read More
Sep 30
Love0

FULL SUPPLEMENT: The Importance of Skincare in Eczema: A Novel Over-the-Counter Routine Improves Signs and Symptoms in Patients with Eczema

By Chuck Lin No Comments
In this supplement:Efficacy of Over-The-Counter Cream in Reducing Eczema SignsEczema affects approximately 31 million people in the United States and is characterized by dryness, itchiness, scaling, roughness, irritation, or discoloration…
Read More
Sep 29
Love0

Comparing the Efficacy for Pulse Versus Continuous Dose Terbinafine Therapy in Patients With Onychomycosis

By Chuck Lin No Comments
INTRODUCTIONOnychomycosis is a fungal infection of the nails and surrounding skin often presenting as thickening of the nail, onycholysis, and discoloration. It is the most common nail pathology and accounts…
Read More
Sep 29
Love0

The Psychosocial Burden of Skin Disease and Dermatology Care Insights Among Skin of Color Consumers

By Chuck Lin No Comments
IntroductionAcute and chronic skin conditions affecting the appearance of visible skin are associated with both physical and psychological symptoms and lower quality of life.1,2 In individuals with skin of color,…
Read More
Sep 29
Love0

Ant Venom-Based Ceramide Therapy Is Effective Against Atopic Dermatitis In Vivo

By Chuck Lin No Comments
INTRODUCTIONAtopic dermatitis (AD) is one of the most common inflammatory skin disorders. It is present in both the very young and the very old and is a significant cause of…
Read More
Sep 29
Love0

Mechanism of Action of Brodalumab May Correlate With Efficacy in Patients With Inflammatory Skin Diseases

By Chuck Lin No Comments
INTRODUCTIONLong-term maintenance of clear skin is a primary treatment goal for most patients with psoriasis. Ineffective response or loss of response to systemic therapy necessitates a change in treatment. In…
Read More
Sep 29
Love0

Unexpected Clinical Lessons Learned From IL-4 and IL-13 Blockade

By Chuck Lin No Comments
INTRODUCTION1. IL-4 and IL-13 Blockade is Not Immunosuppressive Treating widespread, moderate-to-severe atopic dermatitis (AD) has classically been done with immunosuppressive medications, such as methotrexate, cyclosporine, or azathioprine. Dupilumab changed this…
Read More
Sep 29
Love0

Topical Ivermectin Is Associated With Improved Erythematotelangiectatic, Papulopustular, and Phymatous Rosacea in a Secondary Analysis

By Chuck Lin No Comments
INTRODUCTIONRosacea has variable clinical presentation consisting of four overlapping phenotypes: erythematotelangiectatic, papulopustular, phymatous, and ocular.1 Rosacea's pathogenesis involves increased cutaneous density of Demodex folliculorum mites, which drive inflammation through activation…
Read More
Sep 29
Love0

Updates in the Treatment of Body-Focused Repetitive Disorders

By Chuck Lin No Comments
INTRODUCTION Body-focused repetitive disorders (BFRBs) are psychocutaneous disorders that are underrecognized and undertreated. They are characterized by the performance of a specific body-focused repetitive behavior (eg, hair pulling, skin picking,…
Read More
Sep 29
Love0

Onychomycosis Treatment Prescribed at Only Twenty Percent of Visits: A Cross-Sectional Analysis of the National Ambulatory Medical Care Survey 2007 to 2016

By Chuck Lin No Comments
INTRODUCTIONOnychomycosis represents the most common nail condition seen in clinical practice amongst adults, comprising 50% of all nail disorders seen in the ambulatory setting.1 Clinically, onychomycosis can present with yellow…
Read More
Sep 29
Love0

Participant Satisfaction of a Community-based Telehealth Clinic for Atopic Dermatitis

By Chuck Lin No Comments
INTRODUCTIONAtopic dermatitis (AD), a chronic, relapsing inflammatory disease that affects more than 30 million children and adults in the US, disproportionally impacts African American (AA) and Hispanic children, with a…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • Treatment Strategy for Refractory Dissecting Cellulitis of the Scalp Using Bimekizumab, Isotretinoin, and Oral Antibiotics February 27, 2026
  • Molecular Insights: Immune and Barrier Dysregulation in Seborrheic Dermatitis February 25, 2026
  • Impact of TNF-α and IL-17 Biologics on Cardiometabolic Outcomes in Hidradenitis Suppurativa: Retrospective Cohort Study February 25, 2026
  • Author Spotlight: David Ciocon MD February 23, 2026
  • Non-Invasive Diagnosis of Sun Damaged Skin: Actinic Keratosis Vs Squamous Cell Carcinoma February 19, 2026

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |     ADVERTISING POLICY  |    MANAGE PREFERENCES  |  YOUR PRIVACY CHOICES

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search

  • x-twitter
  • facebook
  • linkedin
  • instagram